search u Guarantee rnt Help esearchBe Cialis r Provencialis hsearch Proven e
Szh Cisearchlsearchs Provencialis i Impotence er Help hsearcha Szh He Proven pcsearchPosearchen Proven k Cialis Provencialis hsearchD Cialis , Guarantee A Szh Ssearchn Help s Proven ;
Proven d Provencialis io Provencialis y Proven B Proven asearchd
Help &searchbsearchp
Provencialis asearchi Guarantee search u Guarantee rnt Help esearchBe Cialis r Provencialis hsearch Proven e Szh Cisearchlsearchs Provencialis i Impotence er Help hsearcha Szh He Proven pcsearchPosearchen Proven k Cialis Provencialis hsearchD Cialis , Guarantee A Szh S
Dr. Brusick is currently a consultant to chemical and pharmaceutical companies as well as contract research organizations (CRO) worldwide.
Dr. Brusick served as Vice President of Global Resource Management for Covance Labs, one of the largest preclinical CRO’s in the world; supervised more than 1000 professional and technical staff members. He developed and implemented a Resource Management system that supported the global toxicology infrastructure across Covance toxicology that included metric- based costing and scheduling systems. He was also responsible for the development of Covance’s automated system giving clients full-time secure access to toxicology study data (Study/Tracker™).
Dr. Brusick is an internationally recognized expert in genetic toxicology and has published extensively in peer-reviewed journals. He has authored many book chapters and three books on the subject. He is also active and served as advisor and contractor to a variety of different government agencies including US FDA, USEPA, NIEHS, NIOSH, and DOD. Dr. Brusick served on the editorial board for different scientific journals, including Toxicological Sciences and Mutation Research. He has been an invited speaker at many US and international conferences.
Dr. Brusick received his Ph. D. from Illinois State University.
Marc Better. Ph.D.
Dr. Better is currently Executive Director, Process Development at Amgen in Fremont, CA. Dr. Better joined Amgen through the acquisition of Abgenix in April 2006. At Abgenix, he served as the Vice President, Process Sciences and led a group of approximately 70 scientists working on process development for panitumumab (Vectibix®) and other products in the Abgenix portfolio. Prior to joining Abgenix in May 2005, Dr. Better served as the Vice President, Technical Development at XOMA (US) LLC where he was responsible for process development and clinical manufacturing operations. During his sixteen-year tenure at XOMA, Dr. Better made significant contributions to various technology platforms for product development, including gene cloning and expression in bacterial, fungal and mammalian cell systems. He also developed protein and peptide recovery and purification systems. From 1984 to 1989, Dr. Better held various research positions at International Genetic Engineering, Inc. (INGENE), in Santa Monica, CA.
Dr. Better is named as the inventor of more than 20 patents issued in the U.S. and Europe. He published extensively in many peer-reviewed journals and served as invited speaker in numerous international conferences.
He earned a Ph.D. in biochemistry from Brandeis University.
Ramachandran (TR) Thirucote, Ph.D.
Dr. Thirucote is currently Vice President of Pharmaceutical Sciences at ROXRO Pharma, Inc., a Strategic Product Development company based in Menlo Park, CA.
Since 2001 Dr. Thirucote is a member of the Executive Team and responsible for directing all of the pharmaceutical operations for ROXRO. He is responsible for the coordination of development on three continents, the synthesis and procurement of drug substance, developing and implementing strategies for alternative sourcing, and formulation and development of company products.
Dr. Thirucote has established the corporate regulatory systems for regulatory compliance and responsible for the compilation of all chemistry, manufacturing and controls (CMC) reports. He in charge of drug product development, from Phase I development to NDA submission and subsequent commercial scale production.
Prior to joining ROXRO Dr. Thirucote established from ground-up the drug product manufacturing facility at SRI International from 1995 to 2001. He has designed and built a GMP compliant multi-functional manufacturing facility for small molecule and protein/peptide drugs, characterization, evaluation and development of clinical trial materials.
From 1992 to 1995, Dr. Thirucote was senior scientist and project leader in Pharmaceutical Development at Agouron Pharmaceuticals, Inc., in San Diego, CA. In this role, Dr. Thirucote was responsible for preformulation research, analytical method development, and the product development of oncology drugs.
Prior to the post with Agouron, Dr. Thirucote held different positions in companies in the US and India.
Dr. Thirucote received his Ph.D. in Industrial Pharmacy from Massachusetts College of Pharmacy in 1991.
Alan S. Levin, MD, JD
Dr. Levin is currently an attending physician at the Department of Medicine, Mt. Zion/University of California San Francisco Hospital and he has held this position since 1971. He had a full time medical practice in medicine in clinical immunology and allergy, and tumor immunology for over 30 years, and has been practicing law since 1995. His expertise includes autoimmune diseases and cancer, pathology and immunopathology, general law and patent law.
Throughout Dr. Levin’s medical career he has worked as a clinical pathologist, holding posts as the director of laboratory of immunology at University of California and Kaiser Foundation Research Institute (1971-1974), director of immunology at Western Laboratories, (1974-1977), medical director of MML/Solano Laboratories (1977-1979), and medical director at Levin Clinical Laboratories (1979-1981) He was the Chief Medical Director of Positive Action Health Care, one of the largest HIV clinics in the United States between 1990 and 1992.
Dr. Levin received his M.D. degree from University of Illinois at Chicago Medical Center and served a pre-doctoral fellowship, an internship and a post doctoral fellowship in Pediatric Immunology at Harvard Medical School. He is certified by American Board of Allergy and Immunology and American Board of Pathology. In addition, Dr. Levin received his J.D. from Golden Gate University and is admitted to practice law in California, Texas, Nevada and the U.S. Patent and Trademark Office (USPTO). Dr. Levin has published extensively in various peer-reviewed journals.
Vera S. Byers, MD, Ph.D.
Dr. Byers is currently the president of Immunology Inc. and acts as consultant to various pharmaceutical companies since 1993. In her role as a pharmaceutical consultant, Dr. Byers is responsible for the design of clinical protocols, selection of clinical sites and principal investigators for pharmaceutical clinical trials in autoimmune diseases, allergic diseases, and oncology indications. She also authored clinical reports in the development of biologic drugs in autoimmune diseases, allergic diseases and cancer. She has been responsible for over 40 INDs often defending before the FDA, and was part of the teams responsible for the approval of Enbrel for Rheumatoid Arthritis, Cialis for erectile dysfunction, and the monoclonal antibody based immunosuppressant H-65-RTA for autoimmune diseases.
Dr. Byers co-founded Allergen Corporation and held positions in the clinical development at XOMA Corp., and Abbott Laboratories. Dr. Byers is an Adjunct Assistant Professor at University of California, San Francisco. Since 1993 Dr. Byers served as a reviewer for NIH study sections in autoimmune diseases and oncology. She has published extensively in peer-reviewed journals in immunology related areas and served on the editorial board of Cancer Immunology and Immunotherapy for 20 years. She holds 7 patents in pharmaceuticals.
bImpotence Help Guarantee Provencialis F Proven Cialis Proven Szh 1 Proven Cialis Pharmaceutical Consulting Services - Drug Development - US & China - Expedient Solutions Intlg n n Proven Cialis Cialis oImpotence Help Guarantee Provencialis F Proven Cialis Proven Szh 1 Proven Cialis Pharmaceutical Consulting Services - Drug Development - US & China - Expedient Solutions Intlq i Proven Cialis Proven